Josh Wolfe & Brett McGurk – Venture, Geopolitics, and the Next Frontier (EP.476)

What It Covers

Josh Wolfe and Brett McGurk of Lux Capital discuss venture industry bifurcation between small undercapitalized funds and mega-funds, the shift from software to physical infrastructure investing, geopolitical risks, and directional arrows of progress in AI inference, defense technology, and biology.

Key Questions Answered

• •Venture Fund Extinction: 50-90% of subscale venture funds under $500 million will face involuntary exit due to under-reservation, over-investment in too many portfolio companies, and inability to support follow-on rounds. These funds benefited from abundant capital six to eight years ago but now face broken syndicates and down rounds as companies return for funding.
• •AI Infrastructure Overcapacity: Training costs at Anthropic escalated from $100 million to $10 billion while revenue growth plateaued at $7 billion, creating unsustainable capital expenditure dynamics. The collective behavior of companies spending 500% on infrastructure while competing for 20% market share each represents irrational allocation that will collapse when debt enters the system through recent Facebook and CoreWeave issuances.
• •Edge Inference Shift: 50% of AI inference will migrate from cloud data centers to on-device processing using flash memory chips from SK Hynix, Samsung, and Micron. This transition undermines the consensus narrative of endless demand for GPUs and data centers, creating opportunities in edge inference chips and local model hosting on phones, watches, and wearables.
• •Maintenance CapEx Cycle: After ten years of growth capital expenditure in buildings, data centers, satellites, and military installations, the pendulum shifts to maintenance CapEx. Technologies for asset maintenance including software, acoustic detection sensors for machine aberrations, and remote repair robots represent the next investment wave as CFOs prioritize existing asset optimization over new deployment.
• •Automated Science Labs: Biology research transitions from physical wet benches to cloud-operated robotic labs where scientists design experiments remotely via iPad, receive automated results, and get AI-prompted suggestions for follow-up studies based on historical papers. Countries and companies mastering this shift will produce massive knowledge advantages in materials and drug discovery through decoupling scientists from physical laboratory constraints.